These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 34034264

  • 1. The Effectiveness of Antibiotic-Coated Ventriculoperitoneal Shunts for Prevention of Shunt Infections in Patients with Myelomeningocele.
    Ertuğrul B, Kaplan M, Batu Hergünsel Ö, Akgün B, Öztürk S, Serhat Erol F.
    Pediatr Neurosurg; 2021; 56(4):357-360. PubMed ID: 34034264
    [Abstract] [Full Text] [Related]

  • 2. Impact of dual procedures: How combining VP shunt placement for hydrocephalus and myelomeningocele repair in newborns affects complication rates?
    Kadri H, Agha MS, Abouharb R, Mackieh R, Bakleh S, Almasri M, Kadri T.
    Neurosurg Rev; 2024 Jul 20; 47(1):343. PubMed ID: 39031287
    [Abstract] [Full Text] [Related]

  • 3. Shunt revision rates in myelomeningocele patients in the first year of life: a retrospective study of 52 patients.
    Alatas I, Canaz G, Kayran NA, Kara N, Canaz H.
    Childs Nerv Syst; 2018 May 20; 34(5):919-923. PubMed ID: 29159427
    [Abstract] [Full Text] [Related]

  • 4. A retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics.
    Clemmensen D, Rasmussen MM, Mosdal C.
    Childs Nerv Syst; 2010 Nov 20; 26(11):1517-21. PubMed ID: 20221611
    [Abstract] [Full Text] [Related]

  • 5. The Association between the Timing of Shunt Placement and Shunt Infection in Hydrocephalus Associated with Myelomeningocele.
    Gurbuz MS, Yuksel MO.
    Turk Neurosurg; 2020 Nov 20; 30(1):94-98. PubMed ID: 31452179
    [Abstract] [Full Text] [Related]

  • 6. Shunt infection and malfunction in patients with myelomeningocele.
    White MD, McDowell MM, Agarwal N, Greene S.
    J Neurosurg Pediatr; 2021 May 01; 27(5):518-524. PubMed ID: 33636695
    [Abstract] [Full Text] [Related]

  • 7. First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).
    Elbabaa SK, Gildehaus AM, Pierson MJ, Albers JA, Vlastos EJ.
    Childs Nerv Syst; 2017 Jul 01; 33(7):1157-1168. PubMed ID: 28470384
    [Abstract] [Full Text] [Related]

  • 8. Clinical and ultrasonographic criteria for using ventriculoperitoneal shunts in newborns with myelomeningocele.
    Melo JR, Pacheco P, Melo EN, Vasconcellos Â, Passos RK.
    Arq Neuropsiquiatr; 2015 Sep 01; 73(9):759-63. PubMed ID: 26352494
    [Abstract] [Full Text] [Related]

  • 9. Experience in shunt management on revision free survival in infants with myelomeningocele.
    Al-Hakim S, Schaumann A, Schneider J, Schulz M, Thomale UW.
    Childs Nerv Syst; 2018 Jul 01; 34(7):1375-1382. PubMed ID: 29582171
    [Abstract] [Full Text] [Related]

  • 10. Myelomeningocele-associated hydrocephalus: nationwide analysis and systematic review.
    McCarthy DJ, Sheinberg DL, Luther E, McCrea HJ.
    Neurosurg Focus; 2019 Oct 01; 47(4):E5. PubMed ID: 31574479
    [Abstract] [Full Text] [Related]

  • 11. When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus?
    Oktem IS, Menkü A, Ozdemir A.
    Turk Neurosurg; 2008 Oct 01; 18(4):387-91. PubMed ID: 19107685
    [Abstract] [Full Text] [Related]

  • 12. Comparison Of Simultaneous Versus Delayed Ventriculoperitoneal Shunting In Patients Undergoing Meningocoele Repair In Terms Of Infection.
    Khattak HA, Gul N, Khan SA, Muhammad G, Aurangzeb A, Khan I.
    J Ayub Med Coll Abbottabad; 2018 Oct 01; 30(4):520-523. PubMed ID: 30632328
    [Abstract] [Full Text] [Related]

  • 13. Predictors of the need for cerebrospinal fluid diversion in patients with myelomeningocele.
    Phillips BC, Gelsomino M, Pownall AL, Ocal E, Spencer HJ, O'Brien MS, Albert GW.
    J Neurosurg Pediatr; 2014 Aug 01; 14(2):167-72. PubMed ID: 24877604
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Contemporary management and outcome of myelomeningocele: the Rotterdam experience.
    Spoor JKH, Gadjradj PS, Eggink AJ, DeKoninck PLJ, Lutters B, Scheepe JR, van Meeteren J, de Laat PCJ, van Veelen ML, de Jong THR.
    Neurosurg Focus; 2019 Oct 01; 47(4):E3. PubMed ID: 31574477
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of postoperative antibiotic injection in and around ventriculoperitoneal shunt in reduction of shunt infection: A randomized controlled trial.
    Moussa WM, Mohamed MA.
    Clin Neurol Neurosurg; 2016 Apr 01; 143():144-9. PubMed ID: 26945767
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation.
    Mallucci CL, Jenkinson MD, Conroy EJ, Hartley JC, Brown M, Dalton J, Kearns T, Moitt T, Griffiths MJ, Culeddu G, Solomon T, Hughes D, Gamble C, BASICS Study collaborators.
    Lancet; 2019 Oct 26; 394(10208):1530-1539. PubMed ID: 31522843
    [Abstract] [Full Text] [Related]

  • 19. Ventriculoperitoneal shunts in neonates: a retrospective study of outcomes with antibiotic-impregnated catheters and a modified peri-operative antibiotic protocol.
    Jaeger W, Lee S, Vineet D, Keil A, Agarwal N, Rao S.
    Br J Neurosurg; 2017 Dec 26; 31(6):672-676. PubMed ID: 28835126
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.